Gachon University Gil Medical Center opened an artificial intelligence (AI) clinic for people with severe diabetes Monday.
|Professors and other medical workers at Gachon University Gil Medical Center celebrate the opening of the AI-based diabetes center on the third floor of the hospital in Incheon Monday.|
“The advanced diabetes clinic has the latest treatment methods and the expertise and system that parallel the level of advanced countries. The clinic will serve to increase the level of diabetes treatment domestically,” said Professor Kim Byung-joon from Gil Medical Center’s Endocrine-Diabetes Center.
The AI clinic for severe diabetes is on the third floor of the hospital in Incheon and will provide high-tech treatment for patients who have various diabetes complications and difficulty controlling blood glucose. People with severe or high-risk diabetes include those who cannot secrete insulin, have severe chronic complications such as retinopathy before blindness and have to get at least four injections of insulin per day to control blood sugar, among others.
The clinic will provide medical services, including allogeneic and autologous transplantations, multidisciplinary medical service, continuous blood glucose tests, and other specialized procedures, the hospital said. The hospital announced that it would install an advanced insulin pump system with a built-in AI system called the “640 insulin pump” to maintain patient’s blood sugar by predicting the patient’s hypoglycemia in advance and controlling the rate of insulin infusion.
A continuous glucose monitoring system (CGMS) will be linked to the general insulin pump to slow the rate of insulin infusion when blood sugar drops and to accelerate when blood sugar rises, thereby automatically preventing hyperglycemia and hypoglycemia.
The hospital said it also expanded the number of its professional staff and created multi-disciplinary teams to provide higher quality care, especially regarding pancreatic islet transplantation. Gil said it built a separate, multidisciplinary pancreatic islet transplantation team comprised of doctors from various departments such as that of surgery, radiology, internal digestive medicine.
"Medical institutions around the world are taking the initiative in introducing islet transplantations, which have been proven effective,” said Professor Kim Kwang-won, head of the Endocrine-Diabetes Center. “The islet transplant team has raised the success rate of transplantations by creating a separate maintenance protocol and introducing immunotolerance through stem cells and a new immunotherapeutic agent.”
The number of diabetes patients and awareness of complications have been rising in step with the extended lifespan in Korea. According to a national health nutrition survey, the prevalence of the disease surpassed 13 percent last year, and notably increased among those in their 60s and 70s.